Drug study for adults with solid tumors
Part of Cancer clinical trials.
This Phase 1 study tests XZB-0004 in adults with solid cancers to check safety and how the body responds to the drug. It may help doctors learn whether this treatment could be useful for certain tumor types, including non-small cell lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to sign consent and have it signed before any study steps
- Your age must be 18 to under 75
- You must have a confirmed solid cancer (and for one part, non-small cell lung cancer or another solid tumor)
- Your cancer must be measurable or evaluable on scans/tests (per RECIST 1.1)
- Your body strength score (ECOG) must be 0 or 1, and your organs must be healthy enough
- You generally must not have had recent cancer treatment, strong steroids, or other study drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests XTX301, a study treatment, in people with advanced solid tumors (cancers) that have already been treated and are not controlled by standard options. It may help if your cancer matches one of the study groups and you meet safety and test-tissue requirements.
This study tests a new drug called XTX501 for people with advanced non-small cell lung cancer (NSCLC) or other solid tumors. The drug may help the immune system fight cancer, and the study aims to see if it is safe and effective.
This Phase 1/2 trial studies ZGGS18, a new medicine, in people with advanced solid tumors that either no longer respond to standard treatment or for whom standard treatment isn’t an option. The goal is to see how the drug works and what side effects it causes.
This early study tests a new medicine (BPI-460372) in adults with advanced solid cancers that have come back or can’t be treated with standard options. It may help by targeting specific cancer changes in certain tumors, and doctors will also learn the safest dose.
This Phase 1 trial tests a new experimental medicine (FZ-AD004) in adults with advanced solid tumors. It aims to see how the drug behaves in the body and whether it’s safe enough to continue in patients with measurable cancer.
This trial tests a new oral drug (ZX-8177) for people with advanced solid tumors that have stopped responding to standard treatments or cannot be treated with standard options. The goal is to see if it is safe and helps control the disease.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.